You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
Administrator
Staff member
-
cafead   Dec 17, 2024 at 12:12: PM
Administrator
Staff member
via Phase 2 results hinted the partners’ therapy could be more potent than similar inflammatory bowel disease medicines from Merck and Roche.
article source